Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
about
Live attenuated vaccines for invasive Salmonella infectionsVaccines against invasive Salmonella disease: current status and future directionsComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardSynthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteersDevelopment and Evaluation of a Blood Culture PCR Assay for Rapid Detection of Salmonella Paratyphi A in Clinical Samples.Effectiveness of typhoid vaccination in US travelers.Purification and antigenic detection of O-specific polysaccharides of Salmonella enterica serovar Paratyphi A isolate from Pakistan: an emerging threat.Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.Six Cases of Paratyphoid Fever Due to Salmonella Paratyphi A in Travelers Returning from Myanmar Between July 2014 and August 2015.Preventing invasive salmonellosis in children through vaccination.Increase in paratyphoid fever cases in Japanese travellers returning from Cambodia in 2013.Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.Salmonella enterica Paratyphi A Infections in Travelers Returning from Cambodia, United States.Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo.
P2860
Q27003066-5E1B8BD9-BDA3-4406-91AA-DF1739C06CECQ27007088-6870D3E9-CE1B-4A58-8BC3-368B52C1EA7DQ27694492-E5418439-5C20-44E9-BB83-42237501C548Q33577920-7B8D8B51-C3B2-4426-B230-CCADA320D7F7Q33593401-2BF6FAA8-6799-47C4-9A79-E1D41A349629Q35778973-08CD4CBD-8900-418A-936D-08F4CCB2104BQ35941251-BCB86A5F-8DF6-47AD-8EF9-A7CCE825478CQ36159616-884A67E3-EFA8-4A34-B9EF-C501EF0F114CQ37407888-2CCF541C-5425-44C1-AADF-A6CA022E580CQ37551292-2E44A0B5-6669-4728-9781-050AE3472338Q40099382-1D67A6E6-98E2-41FA-B271-9AD312A99782Q40107571-234F6AA8-DE8F-492C-BB8F-A87D16DFECCFQ40147524-A838DB13-DC12-40CE-9440-4B0E84BAC6BEQ40151178-CE2A7E55-7269-4129-8F89-1A54B02D786CQ42787546-C0722848-2558-43E3-9768-C8A0B15B4177Q48505004-E2B6F9F5-7C6C-4E38-BC43-93100403DD85
P2860
Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Increasing rates of Salmonella ...... us of its vaccine development.
@en
type
label
Increasing rates of Salmonella ...... us of its vaccine development.
@en
prefLabel
Increasing rates of Salmonella ...... us of its vaccine development.
@en
P2093
P2860
P1476
Increasing rates of Salmonella ...... us of its vaccine development.
@en
P2093
Rodney Carbis
Sushant Sahastrabuddhe
Thomas F Wierzba
P2860
P304
P356
10.1586/14760584.2013.825450
P50
P577
2013-09-01T00:00:00Z